Link Biologics
Manchester, United Kingdom (UK) · Science and Engineering
Do your work at Link Biologics?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
Jun 2026
Overview
Link Biologics is on a mission to develop Link_TSG6 as a superior treatment for the life-limiting effects of inflammatory and degenerative disorders. Link_TSG6 is based on TSG-6, a human protein with an endogenous role to protect tissues from inflammatory damage.
Our lead programme, Dry Eye Disease (DED), is an inflammatory condition where patients experience persistent eye irritation, blurred vision, pain and decreased quality of life. Approximately 350 million people live with DED worldwide.
Contact Details
info@linkbiologics.co.uk
Manchester, United Kingdom (UK)
Founded
2021
Employees
2-10
Categories
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after Link Biologics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.